In the News: November 8–November 15
By Sg2 TeamThis week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
- Share
This week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
This week: Low-acuity patients are increasingly seeking non-ED treatment; more than one-fifth of US adults report feelings of loneliness; and Medicare ACOs saved CMS $314 million in 2017.
This week: Google continues its push into health care; CMS releases its 2019 inpatient payment final rule; and North Carolina’s transition to managed Medicaid will involve social determinants of health...
This week: Variation in end-of-life expenditures for cancer patients; leading biotech companies targeting cancer with precision medicine; and inpatient utilization continues to slow.
This week: CMS’s Comprehensive Primary Care initiative improved care delivery; the severity and price of ED visits has increased; and Best Buy’s new health care program targets seniors.
This week: US fertility falls to a record low, Kaiser Permanente invests $200 million to fight homelessness and CMS denies Ohio’s individual mandate waiver.
This week: The market for genetic tests shows rapid growth; patients’ challenges in accessing their own medical records; and ACOs are evaluating whether to renew their MSSP contracts.
This week: Commercial insurers pay different prices for same services within hospitals; CMS’s new rural health strategy; and Americans are less confident in their ability to pay for health care.
This week: Telemedicine continues to thrive despite regulatory hurdles; patients’ growing use of online physician review sites; and health care private equity deals reached $42.6 billion in 2017
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."